910 related articles for article (PubMed ID: 33963054)
21. Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Alabed M; Tayoun AA; Loney T; Uddin M; Senok A; Al Heialy S; Hamoudi R; Kashour T; Alsheikh-Ali A; Hamid Q; Halwani R
Clin Transl Sci; 2020 Nov; 13(6):1048-1054. PubMed ID: 32799423
[TBL] [Abstract][Full Text] [Related]
22. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
Liu W; Reyes HM; Yang JF; Li Y; Stewart KM; Basil MC; Lin SM; Katzen J; Morrisey EE; Weiss SR; You J
J Virol; 2021 May; 95(12):. PubMed ID: 33789998
[TBL] [Abstract][Full Text] [Related]
23. Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell™.
Kumar N; Golhar R; Sharma KS; Holloway JL; Sarangi S; Neuhaus I; Walsh AM; Pitluk ZW
BMC Genomics; 2021 Jan; 22(1):5. PubMed ID: 33407110
[TBL] [Abstract][Full Text] [Related]
24. Control of
Osman IO; Garrec C; de Souza GAP; Zarubica A; Belhaouari DB; Baudoin JP; Lepidi H; Mege JL; Malissen B; Scola B; Devaux CA
Front Cell Infect Microbiol; 2022; 12():798767. PubMed ID: 35601094
[TBL] [Abstract][Full Text] [Related]
25. Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers.
Nakayama T; Lee IT; Jiang S; Matter MS; Yan CH; Overdevest JB; Wu CT; Goltsev Y; Shih LC; Liao CK; Zhu B; Bai Y; Lidsky P; Xiao Y; Zarabanda D; Yang A; Easwaran M; Schürch CM; Chu P; Chen H; Stalder AK; McIlwain DR; Borchard NA; Gall PA; Dholakia SS; Le W; Xu L; Tai CJ; Yeh TH; Erickson-Direnzo E; Duran JM; Mertz KD; Hwang PH; Haslbauer JD; Jackson PK; Menter T; Andino R; Canoll PD; DeConde AS; Patel ZM; Tzankov A; Nolan GP; Nayak JV
Cell Rep Med; 2021 Oct; 2(10):100421. PubMed ID: 34604819
[TBL] [Abstract][Full Text] [Related]
26. Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs.
Rath S; Perikala V; Jena AB; Dandapat J
Biomed Pharmacother; 2021 Nov; 143():112095. PubMed ID: 34479017
[TBL] [Abstract][Full Text] [Related]
27. Syncytia formation by SARS-CoV-2-infected cells.
Buchrieser J; Dufloo J; Hubert M; Monel B; Planas D; Rajah MM; Planchais C; Porrot F; Guivel-Benhassine F; Van der Werf S; Casartelli N; Mouquet H; Bruel T; Schwartz O
EMBO J; 2020 Dec; 39(23):e106267. PubMed ID: 33051876
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues.
Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Li N; Tian M; Jin N; Li X
J Virol; 2021 Nov; 95(24):e0153721. PubMed ID: 34550769
[TBL] [Abstract][Full Text] [Related]
29. HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells.
Trionfetti F; Alonzi T; Bontempi G; Terri M; Battistelli C; Montaldo C; Repele F; Rotili D; Valente S; Zwergel C; Matusali G; Maggi F; Goletti D; Tripodi M; Mai A; Strippoli R
Front Cell Infect Microbiol; 2023; 13():1257683. PubMed ID: 38162580
[TBL] [Abstract][Full Text] [Related]
30. Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein.
Sagar S; Rathinavel AK; Lutz WE; Struble LR; Khurana S; Schnaubelt AT; Mishra NK; Guda C; Palermo NY; Broadhurst MJ; Hoffmann T; Bayles KW; Reid SPM; Borgstahl GEO; Radhakrishnan P
Clin Transl Med; 2021 Feb; 11(2):e281. PubMed ID: 33635001
[No Abstract] [Full Text] [Related]
31. TMPRSS2 isoform 1 downregulation by G-quadruplex stabilization induces SARS-CoV-2 replication arrest.
De Magis A; Schult P; Schönleber A; Linke R; Ludwig KU; Kümmerer BM; Paeschke K
BMC Biol; 2024 Jan; 22(1):5. PubMed ID: 38185627
[TBL] [Abstract][Full Text] [Related]
32. Genetic and epigenetic factors associated with increased severity of Covid-19.
Yildirim Z; Sahin OS; Yazar S; Bozok Cetintas V
Cell Biol Int; 2021 Jun; 45(6):1158-1174. PubMed ID: 33590936
[TBL] [Abstract][Full Text] [Related]
33. Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom.
Kerslake R; Hall M; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Mol Med; 2020 Sep; 46(3):949-956. PubMed ID: 32705281
[TBL] [Abstract][Full Text] [Related]
34. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma.
Geng J; Chen L; Yuan Y; Wang K; Wang Y; Qin C; Wu G; Chen R; Zhang Z; Wei D; Du P; Zhang J; Lin P; Zhang K; Deng Y; Xu K; Liu J; Sun X; Guo T; Yang X; Wu J; Jiang J; Li L; Zhang K; Wang Z; Zhang J; Yan Q; Zhu H; Zheng Z; Miao J; Fu X; Yang F; Chen X; Tang H; Zhang Y; Shi Y; Zhu Y; Pei Z; Huo F; Liang X; Wang Y; Wang Q; Xie W; Li Y; Shi M; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2021 Sep; 6(1):347. PubMed ID: 34564690
[TBL] [Abstract][Full Text] [Related]
35. Amuvatinib Blocks SARS-CoV-2 Infection at the Entry Step of the Viral Life Cycle.
Huynh TTX; Pham TX; Lee GH; Lee JB; Lee SG; Tark D; Lim YS; Hwang SB
Microbiol Spectr; 2023 Jun; 11(3):e0510522. PubMed ID: 36995225
[TBL] [Abstract][Full Text] [Related]
36. Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: A versatile and practical infection model for antiviral research and beyond.
Salgado-Benvindo C; Tas A; Zevenhoven-Dobbe JC; van der Meer Y; Sidorov IA; Leijs AA; Wanningen P; Gelderloos AT; van Kasteren PB; Snijder EJ; van Hemert MJ
Antiviral Res; 2024 Jul; 227():105903. PubMed ID: 38723907
[TBL] [Abstract][Full Text] [Related]
37. Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19.
Talebi T; Masoumi T; Heshmatzad K; Hesami M; Maleki M; Kalayinia S
Genet Res (Camb); 2023; 2023():2593199. PubMed ID: 38074420
[TBL] [Abstract][Full Text] [Related]
38. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.
Butler D; Mozsary C; Meydan C; Foox J; Rosiene J; Shaiber A; Danko D; Afshinnekoo E; MacKay M; Sedlazeck FJ; Ivanov NA; Sierra M; Pohle D; Zietz M; Gisladottir U; Ramlall V; Sholle ET; Schenck EJ; Westover CD; Hassan C; Ryon K; Young B; Bhattacharya C; Ng DL; Granados AC; Santos YA; Servellita V; Federman S; Ruggiero P; Fungtammasan A; Chin CS; Pearson NM; Langhorst BW; Tanner NA; Kim Y; Reeves JW; Hether TD; Warren SE; Bailey M; Gawrys J; Meleshko D; Xu D; Couto-Rodriguez M; Nagy-Szakal D; Barrows J; Wells H; O'Hara NB; Rosenfeld JA; Chen Y; Steel PAD; Shemesh AJ; Xiang J; Thierry-Mieg J; Thierry-Mieg D; Iftner A; Bezdan D; Sanchez E; Campion TR; Sipley J; Cong L; Craney A; Velu P; Melnick AM; Shapira S; Hajirasouliha I; Borczuk A; Iftner T; Salvatore M; Loda M; Westblade LF; Cushing M; Wu S; Levy S; Chiu C; Schwartz RE; Tatonetti N; Rennert H; Imielinski M; Mason CE
Nat Commun; 2021 Mar; 12(1):1660. PubMed ID: 33712587
[TBL] [Abstract][Full Text] [Related]
39. The cardiovascular aspect of COVID-19.
Adu-Amankwaah J; Mprah R; Adekunle AO; Ndzie Noah ML; Adzika GK; Machuki JO; Sun H
Ann Med; 2021 Dec; 53(1):227-236. PubMed ID: 33345626
[TBL] [Abstract][Full Text] [Related]
40. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells.
Wing PAC; Keeley TP; Zhuang X; Lee JY; Prange-Barczynska M; Tsukuda S; Morgan SB; Harding AC; Argles ILA; Kurlekar S; Noerenberg M; Thompson CP; Huang KA; Balfe P; Watashi K; Castello A; Hinks TSC; James W; Ratcliffe PJ; Davis I; Hodson EJ; Bishop T; McKeating JA
Cell Rep; 2021 Apr; 35(3):109020. PubMed ID: 33852916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
